Stay updated on LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page.

Latest updates to the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page has removed the 'Last Update Posted (Estimated)' section and replaced it with a more definitive 'Last Update Posted' label.SummaryDifference0.0%
- Check13 days agoChange DetectedThe page has been updated to reflect new dates and a revision change, indicating a recent update to the content.SummaryDifference0.4%
- Check20 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check56 days agoChange DetectedThe webpage has updated its date references, adding new dates in April 2025 while removing older dates from February 2025.SummaryDifference0.5%
- Check64 days agoChange DetectedThe page has been updated to include new drug information, specifically the addition of Alpelisib and Pertuzumab, while significant details about the previous study involving LY3484356 have been removed.SummaryDifference17%
Stay in the know with updates to LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page.